MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
MiR-584-5p potentiates vincristine and radiation response by inducing spindle defects and DNA damage in medulloblastoma.	https://doi.org/10.1038/s41467-018-06808-8	2018	Cell line 4 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
A new module in neural differentiation control: two microRNAs upregulated by retinoic acid, miR-9 and -103, target the differentiation inhibitor ID2	https://doi.org/10.1371/journal.pone.0040269	2012	Cell line 4 Master/Detail View	Cell line and drug 4 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Regulation of UHRF1 by microRNA-378 modulates medulloblastoma cell proliferation and apoptosis.	https://doi.org/10.3892/or.2017.5939	2017	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Restoration of miR-30a expression inhibits growth, tumorigenicity of medulloblastoma cells accompanied by autophagy inhibition.	https://doi.org/10.1016/j.bbrc.2017.07.140	2017	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Suppression of STAT3 NH2 -terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de-repression by microRNA-21.	https://doi.org/10.1002/mc.22778	2018	Cell line 0 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Tissue Factor Regulation by miR-520g in Primitive Neuronal Brain Tumor Cells: A Possible Link between Oncomirs and the Vascular Tumor Microenvironment.	https://doi.org/10.1016/j.ajpath.2015.10.020	2016	Cell line 2 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.	https://doi.org/10.4161/rna.8.5.16041	2011	Cell line 5 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Overexpression of miR-7-1 increases efficacy of green tea polyphenols for induction of apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-DZ cells	https://doi.org/10.1007/s11064-012-0936-5	2013	Cell line 0 Master/Detail View	Cell line and drug 12 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells	https://doi.org/10.1016/j.brainres.2012.03.017	2012	Cell line 0 Master/Detail View	Cell line and drug 12 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
GLIPR1 inhibits the proliferation and induces the differentiation of cancer-initiating cells by regulating miR-16 in osteosarcoma	https://doi.org/10.3892/or.2016.4949	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma	https://doi.org/10.1016/j.jbo.2016.05.001	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-193b Increases the Chemosensitivity of Osteosarcoma Cells by Promoting FEN1-Mediated Autophagy	https://doi.org/10.2147/OTT.S219977	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-143 regulates the proliferation and migration of osteosarcoma cells through targeting MAPK7	https://doi.org/10.1016/j.abb.2017.07.011	2017	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7	https://doi.org/10.1007/s10238-015-0398-6	2017	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell death	https://doi.org/10.1038/onc.2016.68	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Expression and regulatory effects of microRNA-182 in osteosarcoma cells: A pilot study	https://doi.org/10.3892/ol.2016.4375	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-504 promotes tumour growth and metastasis in human osteosarcoma by targeting TP53INP1	https://doi.org/10.3892/or.2017.5983	2017	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a	https://doi.org/10.1016/j.febslet.2013.09.044	2013	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma	https://doi.org/10.1186/s12935-017-0499-2	2018	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MicroRNA-23a promotes neuroblastoma cell metastasis by targeting CDH1	https://doi.org/10.3892/ol.2014.1794	2014	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications